Luhan Pharmachem Co., Ltd. supplies Moxifloxacin HCl bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Moxifloxacin HCl is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.
Moxifloxacin Hydrochloride is an antibiotic used to treat adults with bacterial infections of the lungs, seek sinuses, pills skin, and abdominal cavity. It belongs to a family of quinolone antibiotics that includes ciprofloxacin, ofloxacin, and levofloxacin. It is a broad spectrum antibiotics, meaning that it is effective against a wide range of different types of bacteria.
Moxifloxacin is an effective antibiotic against many strains of both gram negative and gram positive bacteria.
The indications for moxifloxacin include:
Moxifloxacin comes in 400 milligram tablets taken by mouth. The drug can also be administered in intravenous (IV) form (the IV solution contains 400 mg of moxifloxacin). Moxifloxacin hydrochloride is also manufactured as a 0.5% opthalmic solution.
The oral form of moxfloxacin is taken once a day with or without food and with plenty of fluids. The intravenous dosing is also once a day.
Moxifloxacin hydrochloride is a quinolone antibiotic. It inhibits the action of enzymes called topoisomerase II (DNA-gyrase) and topoisomerase IV. These enzymes are found within bacterial cells and work to transcribe and repair the deoxyribonucleic acid (DNA) that the bacteria use in order to multiply. When these enzymes are not allowed to function properly, the bacteria will die. Moxifloxacin can kill many types of bacteria including some that can cause pneumonia, bronchitis, and sinusitis.
The drug is well absorbed from the gastrointestinal tract. Bioavailability is approximately 90% The drug’s half life is 12 hours and steady-state concentration is reached after three days at the 400 mg dose. Approximately 45% of the drug is excreted unchanged in the urine and feces. The dose does not need to be adjusted in the elderly or in people with decreased kidney function.
The benefits of moxifloxacin include once/daily dosing and an easy adjustment from IV dosing to oral dosing. It has been shown to be an effective therapy for community-aquired pneumonia, exacerbation of acute bronchitis and sinusitits.
The side effects of moxifloxacin are generally mild, but serious side effects have been reported in people taking other drugs in this family. These reactions may occur after taking just one dose and include:
Other less severe side effects may include:
Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.
Tel: +86 0871 6511 0906 (GMT+8 AM9:00-AM:12:00 PM1:30-PM6:00)
cell phone:188 1221 6310
Fax:0871-63602606
Email: info@luhancn.com
Address:Room 3301,33rd Floor Building B, Vogue Garden Plaza, No.1004 Beijing Road, Kunming, Yunnan Province, P. R. China 650000